NO305273B1 - Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse derav - Google Patents
Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse deravInfo
- Publication number
- NO305273B1 NO305273B1 NO944991A NO944991A NO305273B1 NO 305273 B1 NO305273 B1 NO 305273B1 NO 944991 A NO944991 A NO 944991A NO 944991 A NO944991 A NO 944991A NO 305273 B1 NO305273 B1 NO 305273B1
- Authority
- NO
- Norway
- Prior art keywords
- steroid
- dosage unit
- pharmaceutical dosage
- sugar coated
- coated pharmaceutical
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 4
- ATXHVCQZZJYMCF-XUDSTZEESA-N Allylestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)CC=C)[C@@H]4[C@@H]3CCC2=C1 ATXHVCQZZJYMCF-XUDSTZEESA-N 0.000 abstract 1
- YNVGQYHLRCDXFQ-XGXHKTLJSA-N Lynestrenol Chemical compound C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 YNVGQYHLRCDXFQ-XGXHKTLJSA-N 0.000 abstract 1
- 229960002692 allylestrenol Drugs 0.000 abstract 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 1
- 229960004976 desogestrel Drugs 0.000 abstract 1
- AOXRBFRFYPMWLR-XGXHKTLJSA-N ethylestrenol Chemical compound C1CC2=CCCC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](CC)(O)[C@@]1(C)CC2 AOXRBFRFYPMWLR-XGXHKTLJSA-N 0.000 abstract 1
- 229960001460 ethylestrenol Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229960001910 lynestrenol Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93203645 | 1993-12-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO944991D0 NO944991D0 (no) | 1994-12-22 |
| NO944991L NO944991L (no) | 1995-06-26 |
| NO305273B1 true NO305273B1 (no) | 1999-05-03 |
Family
ID=8214236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944991A NO305273B1 (no) | 1993-12-23 | 1994-12-22 | Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse derav |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5662936A (de) |
| EP (1) | EP0659432B1 (de) |
| JP (1) | JPH07206681A (de) |
| KR (1) | KR100330560B1 (de) |
| CN (1) | CN1108929A (de) |
| AT (1) | ATE155039T1 (de) |
| AU (1) | AU685538B2 (de) |
| CA (1) | CA2138451C (de) |
| DE (2) | DE659432T1 (de) |
| DK (1) | DK0659432T3 (de) |
| ES (1) | ES2105501T3 (de) |
| FI (1) | FI116035B (de) |
| GR (1) | GR3024817T3 (de) |
| NO (1) | NO305273B1 (de) |
| NZ (1) | NZ270228A (de) |
| ZA (1) | ZA949929B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
| CA2205897A1 (en) * | 1994-11-22 | 1996-05-30 | Malcolm Cecil Pike | Compositions and methods for contraception and for treatment of benign gynecological disorders |
| US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| ATE195871T1 (de) * | 1997-09-23 | 2000-09-15 | Akzo Nobel Nv | Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung |
| WO2000074754A2 (en) | 1999-06-05 | 2000-12-14 | Innovata Biomed Limited | Delivery system |
| GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| CZ20021198A3 (cs) * | 1999-10-11 | 2002-09-11 | Ml Laboratories Plc | Zařízení pro podávání léčiva s povrchovou úpravou odolnou proti vlhkosti |
| US6254888B1 (en) | 2000-01-28 | 2001-07-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for coating pharmaceutical dosage forms |
| EP1269995A1 (de) * | 2000-03-27 | 2003-01-02 | Kyowa Hakko Kogyo Co., Ltd. | Einfach einnehmbares granulat |
| CA2408956C (en) * | 2000-05-18 | 2011-07-12 | Therics, Inc. | Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| JP2002068965A (ja) * | 2000-08-31 | 2002-03-08 | Teikoku Hormone Mfg Co Ltd | 単層糖衣錠及びその製造方法 |
| WO2002036077A2 (en) * | 2000-11-06 | 2002-05-10 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
| US7303763B2 (en) * | 2001-02-12 | 2007-12-04 | Watson Laboratories, Inc. | Compositions for conjugated estrogens and associated methods |
| GB0128148D0 (en) | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
| US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
| EP1744800B1 (de) | 2004-04-21 | 2016-06-22 | Innovata Biomed Limited | Inhalator |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| ATE478564T1 (de) * | 2004-10-15 | 2010-09-15 | Suedzucker Ag | Verbessertes trommelcoating-verfahren |
| JP4808453B2 (ja) * | 2005-08-26 | 2011-11-02 | 株式会社荏原製作所 | 研磨方法及び研磨装置 |
| WO2007035961A2 (en) * | 2005-09-23 | 2007-03-29 | Threshold Pharmaceuticals, Inc. | Anti-cancer therapies |
| CN103281913A (zh) * | 2010-12-29 | 2013-09-04 | 雀巢产品技术援助有限公司 | 包含团聚的油粉的糖果产品 |
| IN2014DN10980A (de) * | 2012-07-03 | 2015-09-18 | Nestec Sa | |
| JP2016501854A (ja) * | 2012-11-22 | 2016-01-21 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ | 粉末組成物から顆粒状産物を製造する方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2736682A (en) * | 1954-10-11 | 1956-02-28 | Victor M Hermelin | Method of making a prolonged action medicinal tablet |
| US3576663A (en) * | 1967-05-29 | 1971-04-27 | Colorcon | Coated tablet |
| US3577512A (en) * | 1968-10-11 | 1971-05-04 | Nat Patent Dev Corp | Sustained release tablets |
| US4390531A (en) * | 1981-08-10 | 1983-06-28 | Syntex Pharmaceuticals International Ltd. | Method of contraception using peak progestogen dosage |
| IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
| IE67345B1 (en) * | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
-
1994
- 1994-12-13 ZA ZA949929A patent/ZA949929B/xx unknown
- 1994-12-19 CA CA002138451A patent/CA2138451C/en not_active Expired - Fee Related
- 1994-12-20 US US08/360,157 patent/US5662936A/en not_active Expired - Lifetime
- 1994-12-20 JP JP6316645A patent/JPH07206681A/ja active Pending
- 1994-12-21 NZ NZ270228A patent/NZ270228A/en not_active IP Right Cessation
- 1994-12-22 DE DE0659432T patent/DE659432T1/de active Pending
- 1994-12-22 DK DK94203732.6T patent/DK0659432T3/da active
- 1994-12-22 FI FI946043A patent/FI116035B/fi active IP Right Grant
- 1994-12-22 NO NO944991A patent/NO305273B1/no not_active IP Right Cessation
- 1994-12-22 ES ES94203732T patent/ES2105501T3/es not_active Expired - Lifetime
- 1994-12-22 EP EP94203732A patent/EP0659432B1/de not_active Expired - Lifetime
- 1994-12-22 AU AU81684/94A patent/AU685538B2/en not_active Ceased
- 1994-12-22 AT AT94203732T patent/ATE155039T1/de not_active IP Right Cessation
- 1994-12-22 CN CN94119182A patent/CN1108929A/zh active Pending
- 1994-12-22 KR KR1019940035926A patent/KR100330560B1/ko not_active Expired - Fee Related
- 1994-12-22 DE DE69404116T patent/DE69404116T2/de not_active Expired - Fee Related
-
1997
- 1997-09-24 GR GR970402451T patent/GR3024817T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI946043A0 (fi) | 1994-12-22 |
| AU8168494A (en) | 1995-06-29 |
| US5662936A (en) | 1997-09-02 |
| CN1108929A (zh) | 1995-09-27 |
| DE69404116D1 (de) | 1997-08-14 |
| FI116035B (fi) | 2005-09-15 |
| EP0659432A1 (de) | 1995-06-28 |
| CA2138451A1 (en) | 1995-06-24 |
| KR100330560B1 (ko) | 2002-09-05 |
| NZ270228A (en) | 1995-09-26 |
| AU685538B2 (en) | 1998-01-22 |
| FI946043L (fi) | 1995-06-24 |
| NO944991D0 (no) | 1994-12-22 |
| DE69404116T2 (de) | 1997-11-13 |
| JPH07206681A (ja) | 1995-08-08 |
| ES2105501T3 (es) | 1997-10-16 |
| CA2138451C (en) | 2007-04-24 |
| ZA949929B (en) | 1995-08-23 |
| NO944991L (no) | 1995-06-26 |
| KR950016715A (ko) | 1995-07-20 |
| GR3024817T3 (en) | 1998-01-30 |
| DE659432T1 (de) | 1997-01-30 |
| DK0659432T3 (da) | 1998-02-16 |
| ATE155039T1 (de) | 1997-07-15 |
| EP0659432B1 (de) | 1997-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO305273B1 (no) | Sukkerbelagt farmas°ytisk doseringsenhet omfattende et steroid og anvendelse derav | |
| IL86089A0 (en) | Pharmaceutical compositions containing certain 17-ketosteroids for the prophylaxis and therapy of retroviral infections | |
| UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| OA09772A (en) | "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". | |
| DK0402950T3 (da) | Behandling af postmenopausale ulemper | |
| CA2163361A1 (en) | Therapeutic substituted guanidines | |
| CA2166332A1 (en) | Antiglucocorticoid steroids for the treatment of anxiety disorders | |
| DE3686022D1 (de) | Monosaccharide enthaltende zusammensetzung zum heilen von wunden. | |
| DK0613687T3 (da) | Anvendelse af pregnanderivat til behandling af tumorer | |
| AU623805B2 (en) | New use of anti-progestomimetic compounds | |
| IT1270905B (it) | Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta | |
| GR1002576B (el) | Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους. | |
| AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
| DK0443957T3 (da) | Hidtil ukendte steroid-forbindelser med en spirogruppe i position 17, en fremgangsmåde og mellemprodukter til fremstilling deraf, deres anvendelse som lægemiddel og farmaceutiske præparater med indhold deraf | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| ITMI913510A1 (it) | Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita' | |
| IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
| AR010857A1 (es) | Esteroides sustituidos en la posicion 11, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que loscontienen | |
| SE9203824D0 (sv) | Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same | |
| HUP9801985A3 (en) | Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis | |
| IL96814A0 (en) | 3-l-(5-thioxo-l-prolyl)thiazolidine-4-carboxylic acid and derivatives therefrom,processes for the preparation thereof and pharmaceutical compositions containing them | |
| ITMI931174A0 (it) | Composizioni farmaceutiche per la cura della talassemia | |
| IL97715A0 (en) | Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer,process for the preparation thereof,and pharmaceutical compositions containing the same | |
| HU00224A9 (en) | Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |